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Interleukin-7 (IL-7) promotes survival and expansion of lymphoid precursors. We show here 
that, in addition, IL-7 has a fundamental role, as early as the stage of the multipotent (B/T/NK) 
common lymphoid progenitor (CLP), in maintaining the B cell differentiation program open. 
CLPs generated in the absence of IL-7 have normal T/NK differentiation potential, but severely 
impaired B potential. Accordingly, CLPs from IL-7–deficient mice express lower amounts of 
early B cell factor (EBF) and Pax5 than wild-type CLPs, but similar amounts of GATA-3. 
Importantly, induced overexpression of EBF is sufficient to restore the B potential in these 
cells. These results indicate that IL-7 directs commitment of CLPs by modulating EBF 
expression. This is the first example of a cytokine influencing lymphoid lineage commitment 
in multipotent progenitors and highlights the relevance of the expression of a functional 
IL-7 receptor at the CLP stage.
 
Differentiation of hematopoietic stem cells
(HSCs) is a stepwise process that begins with
the decision to adopt a myelo-erythroid or a
lymphoid fate, generating progenitors with a
restricted differentiation potential. Common
myeloid progenitors (1) and two populations
of common lymphoid progenitors (CLPs; ref-
erences 2, 3), able to generate exclusively
myelo-erythroid or lymphoid progeny, re-
spectively, have been described in the adult
BM. CLPs are isolated from the lineage (Lin)
 
 
 
fraction, distinguished from HSCs by the ex-
pression of the IL-7R
 
 
 
 and lower levels of c-Kit
and Sca-1, and are clonally able to generate B,
T, and NK progeny but no myelo-erythroid
cells (3). Like conventional CLPs (or CLP-1),
CLP-2  express IL-7R
 
 
 
 and have restricted
lymphoid potential, but are found among pT
 
 
 
-
expressing B220
 
 
 
c-Kit
 
 
 
 cells (2). CLP-2 were
proposed to represent thymic immigrants (4).
A molecular understanding of the signals
that trigger lineage commitment in the hemato-
poietic system has been a challenge for 
 
 
 
10 yr.
According to the instructive model of lineage
commitment, signals in the environment deter-
mine cell fate, inducing differentiation along a
particular pathway. Alternatively, stochastic
models predict that asymmetric cell division
and/or random fluctuations in the pattern of
gene expression lead to heterogeneous distri-
bution of proteins in the progeny of precursor
cells, resulting in lineage commitment. We
proposed previously that embryonic and adult
hematopoiesis obey different rules of commit-
ment, mainly stochastic in the fetus and in-
structive in the adult (5).
Instructive commitment is exemplified by
T cell differentiation in the thymus upon acti-
vation of the Notch1 signaling pathway by
Delta-like Notch1 ligands (6). Notch1 signaling
resolves a binary choice in the lymphoid path-
way between the mutually exclusive programs
of B and T cell differentiation. This is achieved
by regulating RBP/J
 
 
 
 transcriptional activity
(7) and, at least partially, by modulating the
turnover of E2A proteins, which are indis-
pensable for B cell differentiation (8). No
other instructive signals involved in lymphoid
commitment have been positively identified to
date, although several transcription factors are
known to play key roles in commitment and
differentiation. For example, GATA-3 is es-
sential for T cell development, as evidenced by
the inability of GATA-3
 
   
 
 embryonic stem
cells to generate T cells while contributing to
other hematopoietic lineages in complementa-
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tion chimeras (9). NK cell differentiation is largely depen-
dent on DNA-binding protein inhibitors (Id proteins), Id2
in particular (10, 11), which are negative regulators of tran-
scription that counteract the action of helix-loop-helix tran-
scription factors such as E2A (12). E2A and early B cell factor
(EBF) are activators of the B cell differentiation program and
have been implicated in the regulation of B cell–specific
genes, such as mb-1, 
 
 
 
5, VpreB, and probably Pax5 (13).
Targeted disruption of either E2A (14, 15) or EBF (16) abol-
ishes B cell development before D-J
 
H
 
 rearrangements occur.
Pax5 is necessary to fix the B-committed status by positively
regulating lineage-specific genes such as CD19 and B cell-
linker and by repressing nonlymphoid genes such as M-CSFR
(13). B cell differentiation is blocked at the pro–B cell stage in
Pax5
 
   
 
 mutants (17), and these precursors retain the ability to
differentiate into other hematopoietic lineages (18, 19).
Although a role for cytokines in the commitment of he-
matopoietic progenitors is suspected, this is still a matter of
debate. CLPs ectopically expressing hIL-2R
 
 
 
 or hGM-
CSFR differentiate into myeloid cells upon stimulation with
hIL-2 or hGM-CSF, respectively (20, 21), and G-CSF sig-
nals were shown to regulate granulocytic versus monocytic
differentiation (22). These observations indicate that, in ad-
dition to modulation of proliferation and survival, cytokine
signals may instruct cell lineage decisions.
No signals upstream of the cascade of events that lead to
B cell differentiation have been described yet, but it is well
known that cytokines produced by stromal cells are impor-
tant players in B cell development (23, 24). In particular, IL-7
is known to be essential for the survival, expansion, and
differentiation of committed B cell precursors in adult mice
(25–29), although no role has been formally demonstrated
for this cytokine in the process of B cell commitment itself.
It has been shown that IL-7 supports in vitro B cell differen-
tiation from CLPs with a parallel loss of T cell potential (27),
but this result is compatible with the notion that IL-7 is a
survival factor for progenitors that stochastically entered the
B cell pathway and does not demonstrate direct involvement
of IL-7 in B cell commitment.
Production of B cells is completely abolished in the BM
of adult IL-7
 
   
 
 mice, with a developmental arrest occurring
before D-J
 
H
 
 rearrangement (fraction A; references 25, 28).
A small yet persistent peripheral B cell pool is maintained,
whose production is supported during fetal and perinatal life
by the IL-7–related cytokine thymic-stromal lymphopoietin
(TSLP; reference 30). The development of 
 
  
 
 T cells is
partially arrested at the DN2 stage in IL-7
 
   
 
 mice, but a
normal percentage of thymic CD4/CD8 double positive
cells is always found (31). At the same time, the production
of 
 
  
 
 T cells is completely abolished and NK cell develop-
ment is not compromised by the absence of IL-7 (31).
In this work, we studied the role of IL-7 in lymphoid
lineage commitment through quantitative analysis in in vitro
limiting dilution assays of the differentiation potential of
lymphoid progenitors from IL-7
 
   
 
 mice. We observed that
IL-7
 
   
 
 CLPs, despite being able to generate T and NK cells
at near normal frequency, are largely devoid of B cell poten-
tial. Thus, the developmental arrest in B cell development,
observed in the absence of IL-7, occurs at the CLP stage,
earlier than previously thought (27, 32). Adult IL-7
 
   
 
 CLPs
express lower amounts of the B cell–specific transcription
factors EBF and Pax5 than control CLPs. Notably, overex-
pression of 
 
Ebf
 
 in these cells rescues their ability to give rise
to B cell progeny. Therefore, this work discloses a thus far
unsuspected role of IL-7 in the modulation of 
 
Ebf
 
 expres-
sion, already at the CLP stage, to maintain the B cell differ-
entiation program open.
 
RESULTS
CLPs in the BM of adult IL-7
 
 
 
/
 
 
 
 mice
 
In the BM of mice deficient for IL-7, B cell production is
completely abolished, with a developmental arrest occurring
before the first detectable B lineage committed cells (25).
CLPs are hierarchically positioned between the HSCs and the
earliest committed B cell precursor and are the most immature
progenitors expressing the receptor for IL-7 (3). We investi-
gated the BM of IL-7–deficient mice for the presence of
multipotent CLPs. Flow cytometry analysis showed that
Lin
 
 
 
IL-7R
 
 
 
 
 
c-Kit
 
lo
 
Sca-1
 
 
 
 cells (3) are present in adult IL-7
 
   
 
animals (Fig. 1 A), although reduced in number to 30% of the
wild type (not depicted). The expression of IL-7R
 
 
 
 at the
cell surface is indistinguishable between IL-7
 
   
 
 and wild-
type CLPs (Fig. 1 A). As is the case for wild-type mice (33),
 
 
 
70% of the CLPs from IL-7
 
   
 
 mice express the Flk-2 re-
ceptor (Fig. 1 A). To analyze the in vivo differentiation po-
tential of these cells, we injected 1,000 CLPs from each strain
into irradiated allotype-congenic Rag2
 
 
 
c
 
   
 
 mice. Donor-
derived B (IgM
 
 
 
), T (CD3
 
 
 
), and NK (NK1.1
 
 
 
) progeny
were detected, 5 wk after transplantation, in both cases and
no myeloid reconstitution was observed either in the spleen
or BM of any of the recipient mice (unpublished data). These
results confirm that CLPs from both mouse strains have a
lymphoid-restricted differentiation potential in vivo.
We analyzed the differentiation potential of wild-type
CLPs by in vitro limiting dilution assays. We independently
sorted CLPs expressing low or high levels of Sca-1 and de-
termined the frequency of precursors in each subpopulation,
able to generate B, T, or NK cells (Table S1, available at http:
//www.jem.org/cgi/content/full/jem.20042393/DC1). We
observed that Lin
 
 
 
IL-7R
 
 
 
 
 
c-Kit
 
lo
 
Sca-1
 
 
 
 cells with different
levels of Sca-1 have identical lymphoid differentiation poten-
tial, and in no case was myeloid progeny obtained in these
cultures. Additionally, we measured the frequency of bipo-
tent precursors among wild-type CLPs by culturing single
cells and scoring for precursors that could give rise to B and
NK cells in the same well. Because the conditions that allow
B or T cell differentiation are mutually exclusive, we used
NK differentiation as a surrogate marker for the T cell po-
tential (20). We determined that one out of six CLPs (i.e.,
16.7%) can give rise to both B and NK cells (Fig. 1 B). 
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Taking into account the plating efficiency (i.e., reporting to
the total number of wells with colonies), this result corre-
sponds to a frequency of 1/2 progenitors (i.e., at least 50% of
clonable CLPs qualify as bipotent precursors. These values
are in agreement with published estimates on the frequency
of multipotent precursors among CLPs (3, 20).
 
IL-7 deficiency impairs the differentiation potential of CLPs
 
The differentiation potential of CLPs can only be quantita-
tively analyzed with in vitro assays. Therefore, we performed
limiting dilution assays with CLPs isolated from control and
IL-7
 
   
 
 
 
mice to compare their ability to give rise to lympho-
cytes in the presence of exogenous IL-7. We determined
that wild-type CLPs are at least 25 times more efficient than
CLPs from IL-7
 
   
 
 
 
in generating B lymphocytes (Fig. 1 C
and Table I). Wild-type CLPs generated B cells at frequen-
cies ranging from 1/6 to 1/15, in agreement with previous
data (3), whereas IL-7
 
   
 
 
 
CLPs did so at frequencies from
1/364 to 1/756 (Table I). Although generated at a much-
reduced frequency, the few clones derived from IL-7
 
   
 
CLPs were macroscopically as large as those derived from
wild-type CLPs (unpublished data), consistent with the pres-
ence of B cells in the spleen of recipient mice reconstituted
with CLPs from IL-7
 
   
 
 
 
mice as mentioned before. To de-
termine the frequency at which CLPs are able to generate T
and NK cells, we performed fetal thymic organ cultures
(FTOCs) under limiting dilution conditions and observed
that CLPs from both strains have equivalent T and NK dif-
ferentiation potential. Control CLPs give rise to T cells at a
frequency of 1/7 and to NK cells at a frequency of 1/8,
whereas when IL-7
 
   
 
 CLPs were used, T and NK cells
were generated at frequencies of 1/18 and 1/20, respectively
(Table I). We conclude that IL-7 deficiency does not sub-
stantially affect the T/NK potential of CLPs, but severely
impairs their ability to give rise to B lymphocytes.
 
IL-7 deficiency impairs the differentiation potential of 
Lin
 
 
 
B220
 
 
 
 progenitors
 
The BM of adult IL-7
 
   
 
 
 
mice is completely devoid of
B220
 
 
 
CD19
 
 
 
IgM
 
 
 
 B cell progenitors, but a population of
B220
 
 
 
CD19
 
 
 
IgM
 
 
 
 cells can be identified clearly (25). This
Lin
 
 
 
B220
 
 
 
 population contains the recently described CLP-2
(pT
 
 
 
 
 
B220
 
 
 
c-Kit
 
 
 
; reference 2). To determine whether the
Figure 1. CLPs in adult IL-7 /  mice. (A) Expression of c-Kit and Sca-1 
in Lin  BM cells of adult wild-type (top) or IL-7    (bottom) mice. Boxes 
indicate the gate used to sort HSCs (Lin IL-7R  c-KithiSca-1hi cells; left 
dot plots) or CLPs (Lin IL-7R  c-KitloSca-1  cells; middle dot plots). The 
percentages of CLPs in the Lin IL-7R   fraction of the BM are indicated. 
Expression of IL-7R  at the cell surface of wild-type and IL-7    CLPs 
(left histograms); (solid line) IL-7R  or (dotted line) streptavidin-only control. 
Sorted CLPs were restained with Flk-2 (solid line) or isotype control 
(dotted line) antibodies (right histograms); the percentage of Flk-2  cells 
is indicated. (B) Frequency of multipotent progenitors among Lin IL-
7R  c-KitloSca-1  wild-type cells. Single wild-type CLPs were sorted and 
cultured in conditions optimized for the differentiation of both B and NK 
cells. The percentages of wells with NK cells only, B cells only, or B and NK 
cells are indicated. This result is representative of two independent experi-
ments. (C) Frequency of CLPs able to give rise to B cell colonies when iso-
lated from ( ) wild-type or ( ) IL-7    mice, as determined by limiting 
dilution in vitro (representative experiment). The number of cells plated 
per well is plotted against the percentage of negative wells for the growth 
of B cell colonies (CD19 ). Full lines represent the best-fit regression and 
the dashed line intercepts the vertical axis at 37%. The frequency deter-
mined for each mouse strain is indicated.
 
Table I.
 
Frequency of progenitors from adult mice able to give rise to 
B, T, or NK cells
 
Precursors
Differentiation
potential Experiment
Wild
type IL-7
 
 
 
/
 
 
 
Lin
 
 
 
IL-7
 
 
 
 
 
c-Kit
 
lo
 
Sca-1
 
 
 
B 1 1/6 ND
2 1/14
 
a
 
1/364
 
a
 
3 1/8
 
a
 
1/756
 
a
 
4 1/15
 
a
 
 
 
1/382
 
a
 
T 1/7 1/18
NK 1/8 1/20
Lin
 
 
 
B220
 
 
 
B 1/316
 
a
 
 
 
1/9,000
 
a
 
T 1/57 1/137
NK 1/57 1/119
 
Cell populations were purified from the BM of adult wild-type or IL-7
 
   
 
 mice. The 
frequency of B cell precursors was determined by culture in limiting dilution on OP-9 
stromal cells supplemented with cytokines. The frequency of T and NK precursors was 
determined in FTOCs. The results are representative of at least three independent 
experiments.
 
a
 
Statistically different, P 
 
 
 
 0.001. In all experiments, the frequency of myeloid pre-
cursors, as determined by the detection of CD11b
 
 
 
 cells, was 
 
 
 
1/600. 
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reduction of the B cell potential, with maintenance of T/NK
potential and consequent to IL-7 deficiency, also applied to
other multipotent lymphoid progenitors, we analyzed the dif-
ferentiation potential of Lin
 
 
 
B220
 
 
 
 BM cells by limiting
dilution assays. We observed that the frequency at which this
population is able to generate T or NK cells in FTOCs is not
different in wild-type and IL-7
 
   
 
 mice. In contrast, 
 
 
 
1/9,000
Lin
 
 
 
B220  cells from IL-7    BM were able to generate B
cells, whereas wild-type cells did so at a frequency of 1/316
(Table I). The frequency of B cell progenitors among wild-
type Lin B220  cells is lower than what was reported for
CLP-2 (1/20; reference 4) because CLP-2 (i.e., pT -express-
ing Lin B220 ) constitute only 10% of the Lin B220  BM
population (4). We conclude that IL-7 deficiency also impairs
the B cell differentiation potential of CLP-2 but only mini-
mally affects their T/NK differentiation potential.
IL-7 deficiency does not alter the differentiation potential 
of thymic precursors and HSCs
The hierarchical relation between CLP-1 and CLP-2 as well
as the nature of the thymic immigrants is still a matter of de-
bate. Whatever thymic precursors exist in adult IL-7   
mice, they are functional in vivo, as demonstrated by their
ability to colonize wild-type thymic lobes grafted under the
kidney capsule of IL-7    mice (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20042393/DC1). Such
conditions support a normal T cell development (Fig. S1),
indicating that any step of T cell commitment and differenti-
ation that may occur prethymically must be IL-7 independent.
Thymopoiesis in IL-7    mice is reduced due to the role of
IL-7 at later stages of T cell development, in the expansion
of DN1 and DN2 and at the DN2–DN3 transition (31, 34).
Furthermore, we determined that HSCs (Lin IL-7R  
c-KithiSca-1hi cells) from IL-7–deficient mice are functionally
indistinguishable from their wild-type counterparts in their
ability to generate both B and myeloid cells (Fig. 2). Thus,
contrary to previous suggestions (27, 32), B cell differentia-
tion in the adult BM is affected by the absence of IL-7 as
early as the CLP stage, but not before.
CLPs in the BM of young IL-7 /  mice
During fetal and perinatal life, TSLP is able to drive B lym-
phopoiesis, thus partially compensating for IL-7 deficiency
(30). Accordingly, B220 CD19 IgM  B cell progenitors
can be found in the BM of IL-7    mice until at least 4 wk
of age (25). At this age, we found a normal number of CLPs
in the BM of IL-7    (not depicted) and they generated B
cells in vitro at a frequency ranging from 1/10 to 1/14,
whereas CLPs from wild-type mice differentiated into B
cells at a frequency of 1/2 to 1/3 (Table II). The frequency
obtained with CLPs from young IL-7    is significantly dif-
ferent from adult IL-7    CLPs (P   0.001) and also signifi-
cantly different from the frequency obtained with cells from
young wild-type mice (P   0.001). CLPs from young wild-
type mice generated T and NK cells at frequencies of 1/38
and 1/28, respectively, whereas cells from IL-7    gave rise
to T cells with a frequency of 1/16 and NK cells with a fre-
quency of 1/8 (Table II). We conclude that, already at 4 wk
of age, CLPs from IL-7    mice have impaired B cell differ-
entiation potential, although less pronounced than in adults.
Taking into account both the number and the frequency
at which CLPs generate lymphocytes in each strain of mice,
we calculated the absolute number of CLPs that are able to
give rise to lymphocytes in young and adult individuals. The
number of progenitors capable of generating T lymphocytes
or NK cells is not affected with age by their development in
the absence of IL-7 (unpublished data). In contrast, in IL-7   
mice at 4 wk of age, the number of CLPs able to generate B
cells is already reduced to 17% (P   0.001) of the control,
and further diminished to  1% (P   0.001) by the time the
animals reach adulthood (Fig. 3). We estimate that adult
IL-7    mice have in the two hind limbs  20 CLPs able to
generate B cells (Fig. 3).
Figure 2. Adult IL-7 /  HSCs have B and myeloid differentiation 
potential identical to wild-type HSCs. Frequency of ( ) wild-type or 
( ) IL-7    HSCs able to give rise to B cell or myeloid colonies, as deter-
mined by limiting dilution in vitro. The number of cells plated per well is 
plotted against the percentage of negative wells for the growth of B cell 
(CD19 ) or myeloid (CD11b ) colonies. Solid lines represent the best-fit 
regression and the dashed line intercepts the vertical axis at 37%. The fre-
quencies determined for each mouse strain are indicated. The results are 
representative of two independent experiments.
Table II. Frequency of CLPs from 4-wk-old mice able to give rise to 
B, T, or NK cells
Differentiation potential Experiment Wild type IL-7 / 
B 1 1/2a 1/14a
2 1/3a 1/10a
T 1/38 1/16
NK 1/28 1/8
CLPs were purified from the BM of young wild-type or IL-7    mice. The frequency 
of B cell precursors was determined by culture in limiting dilution on OP-9 stromal 
cells supplemented with cytokines, and the frequency of T and NK precursors was 
determined in FTOCs.
aStatistically different, P   0.001. The frequency of myeloid precursors, as deter-
mined by the detection of CD11b  cells, was  1/190.JEM VOL. 201, March 21, 2005 975
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EBF overexpression rescues the B potential of IL-7 /  CLPs
The transcription factor EBF is specifically expressed during
B cell development and, together with Pax5, contributes to
the establishment of a B cell characteristic profile of gene ex-
pression (13). Both EBF and Pax5 are expressed as early as
the CLP stage, although at a lower level than committed B
cell precursors (reference 35 and unpublished data). In view
of the differential ability of CLPs from adult IL-7    and
control mice to give rise to B and T lymphocytes, we com-
pared by quantitative RT-PCR their expression of B lineage
(Ebf and Pax5) and T lineage (Gata-3)–specific transcription
factors. Although CLPs always express comparable amounts
of Gata-3, at 4 wk of age, CLPs from IL-7    mice already
have half the amount of Ebf. However, in adult IL-7    mice
the amounts of both Ebf and Pax5 are markedly reduced, to
16 and 13% of the wild type, respectively (Fig. 4 A).
The lower amount of Ebf and Pax5 observed in IL-7   
CLPs would readily explain their impaired B cell differentia-
tion potential. To investigate this possibility, we transduced
these cells with retroviral vectors carrying the coding se-
quence of either Pax5 or EBF, or with an empty vector as
control (Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20042393/DC1). The frequency at which
CLPs from wild-type mice generated B cell colonies in cul-
ture was not altered by transduction with either of the vectors
(Fig. 4 B). Transduction of IL-7    CLPs with the Pax5 vec-
tor led to a small increase in the frequency of B cell genera-
tion and this in only one out of three experiments (Fig. 4 C).
In contrast, overexpression of Ebf increased that frequency by
a factor of nine (Fig. 4 C). In three independent experiments,
transduction of IL-7    CLPs with the Ebf vector always re-
stored B lymphocyte generation in vitro. The effect of EBF is
likely to be even higher because only a fraction of CLPs are
in the S/G2/M phases of the cell cycle (3) and, thus, are sus-
ceptible to infection by retroviral vectors. Therefore, we
conclude that Ebf expression restores the B cell differentiation
potential of CLPs from adult IL-7    mice.
DISCUSSION
IL-7 is well known to be an important cytokine in lympho-
cyte development. This work now defines IL-7 as a major
player in lymphoid lineage commitment. Our results identify
the CLP as the earliest developmental stage at which B cell
differentiation is impaired in the adult BM by the absence of
IL-7, earlier than thought previously (27, 32). We show that
in the absence of IL-7 signals, multipotent CLPs do not
achieve wild-type levels of expression of B lineage transcrip-
tion factors and lose their B cell differentiation potential
while retaining T and NK potential. Importantly, the fact
that only Ebf suffices to rescue the B cell potential of IL-7   
CLPs points to IL-7 as a major regulator of Ebf expression al-
ready at the uncommitted lymphoid progenitor stage. IL-7
Figure 3. Absolute number of CLPs with B differentiation potential, 
in the two hind limbs of young and adult mice. The absolute number 
of progenitors able to generate B cells was calculated by multiplying the 
total number of CLPs (four mice in each group) by the frequencies calcu-
lated in limiting dilution assays. Bars indicate the standard deviation for 
three independent experiments. *, statistically significant, P   0.001. 
 , wild-type mice;  , IL-7    mice.
Figure 4. Ebf, but not Pax5, overexpression in IL-7 /  CLPs restores 
their B differentiation potential. (A) Relative expression of Ebf, Pax5, 
and Gata-3 mRNA in CLPs from 4-wk-old and adult (8–12 wk old) mice. 
The amounts of mRNA from each transcription factor were normalized to 
the amount of Hprt mRNA and are plotted as arbitrary units relative to the 
amounts expressed by wild-type CLPs (100 a.u.). (black) Ebf; (gray) Pax5; 
(white) Gata-3. a.u., arbitrary units. The results are representative of two 
independent experiments. Frequency of (B) wild-type or (C) IL-7    CLPs 
able to give rise to B cell colonies after transduction with the retroviral 
vectors ( ) MIEV, ( ) MIEV-Pax5, or ( ) MIEV-EBF, as determined by 
limiting dilution assay. The number of cells plated per well is plotted 
against the percentage of negative wells for the growth of B cell colonies 
(CD19 ). Solid lines represent the best-fit regression and the dashed line 
intercepts the vertical axis at 37%. The frequency obtained with cells 
transduced by each vector is indicated.IL-7 AND B POTENTIAL IN CLPS | Dias et al. 976
determines the differentiation potential of CLPs by actively
maintaining the B cell program open. Our results also indi-
cate that closing the B cell program (i.e., down-modulation
of Ebf) does not irreversibly engage cells in the T–NK differ-
entiation pathway.
We focused our studies on IL-7    mice because B cell
differentiation is completely abolished in adult animals.
These mice also have severely impaired T cell development,
whereas the NK lineage is unaffected. Ligand-deficient mice
are particularly suited to study the role of cytokines in lym-
phopoiesis because precursor populations can be isolated and
functionally characterized both in vitro and in vivo. Most
conclusions drawn to date about the role of IL-7 signaling in
lymphocyte development relied on the study of mice made
deficient for IL-7R  or common  -chain ( c), the two
components of the IL-7 receptor (34, 36). However, the un-
responsiveness of those mice to IL-7 has precluded func-
tional analysis of precursor populations. Additionally, the
conclusions are limited by the fact that both chains are also
components of other cytokine receptor complexes: TSLP
binds IL-7R –TSLP-R (37, 38) and IL-2, -4, -9, -15, and -21
also signal through  c (39). Thus, in IL-7R – or  c-deficient
mice, it is difficult to draw firm conclusions about the roles
of the individual cytokines.
Mice deficient in  c have a normal percentage of cells
with the phenotype of CLPs and it was demonstrated that
IL-7 is sufficient to drive wild-type CLP differentiation
along the B cell pathway in vitro, with a parallel loss in their
ability to generate T cells (27). These results were taken as
evidence that IL-7 signaling is dispensable for the generation
of CLPs from HSCs, but necessary, after CLP generation,
for their survival and differentiation along the B cell pathway
(27). By studying IL-7    mice, we found that although
CLPs can be generated in the absence of IL-7 signals, they
are nonfunctional as B cell progenitors, even upon exposure
to an excess of IL-7 in vitro. The much-reduced frequency
of IL-7    CLPs able to generate B cells necessarily reflects
the specific loss of B potential in multipotent progenitors
(which we determined to be at least 1/6), independently of
the possible concomitant loss of already B-committed pre-
cursors among Lin IL-7R  c-KitloSca-1  cells. The re-
quirement for IL-7 to maintain the B cell but not the T/NK
potential in CLPs is also observed in Lin B220  cells, where
the recently described CLP-2 (2, 4) is found. Therefore, our
results reveal a novel function for IL-7 signaling in the com-
mitment to the B cell lineage by multipotent lymphoid re-
stricted precursors.
It is striking that CLPs (CLP-1 and CLP-2) are only im-
paired in their ability to generate B lymphocytes, and not T
and NK cells. T lineage–restricted precursors were described
recently in the thymus of Ikaros    mice, which have no
identifiable CLPs in the BM (40). Our analysis concerned
the CLP-dependent pathway because we detect T/NK po-
tential in IL-7R   cells with the phenotype of CLPs and
also in the B220  (CLP-2) cells. A population, designated
early lymphocyte precursors (ELPs) with an intermediate
phenotype between HSCs and CLPs, was also described,
which gives rise to all lymphocyte populations and keeps some
myeloid potential (41). Again, our analysis did not directly ad-
dress ELPs. Nevertheless, by being IL-7R  , we predict that
IL-7 deficiency does not affect the B potential of ELPs.
The thymic precursors found in IL-7    mice are able to
migrate to the thymus and, together with early T lineage pro-
genitors (40), likely support adult thymopoiesis in IL-7   
mice. Thymopoiesis in such mice is reduced due to the role of
IL-7, at later stages of T cell development, in the expansion of
DN1 and DN2 and in the transition from DN2 to DN3 (34).
Our finding that IL-7 is essential for the maintenance of the B
cell, but not the T cell, potential of CLPs explains why B cell
numbers are not rescued the same way as T cell numbers by
the overexpression of Bcl-2 (42, 43) or by Bax deficiency (44)
in an IL-7 signaling–deficient background.
The reduction in the number of BM cells from IL-7   
mice that are able to generate B lymphocytes is progressive;
at 4 wk, an age when IL-7–independent B cell generation
occurs due to the substitutive action of TSLP (30), we found
such cells reduced to 17% of controls, whereas in adults, they
were reduced to  1%. Consistent with the important role of
IL-7 at later stages of B cell development, the reduction in
the number of pro–B cells in these animals is even more
marked: 0.8% of control at 4 wk and  0.001% at 7 wk as
published previously (25).
We showed that already at 4 wk of age, IL-7    CLPs
have reduced amounts of Ebf. The amount of Ebf and Pax5
become drastically reduced in adult CLPs, whereas Gata-3
expression is unaffected. Thus, IL-7 signaling is necessary to
maintain the expression of B lineage–related transcription
factors in adult BM cells, as early as the CLP stage. In our
studies, Pax5 overexpression only minimally recovered the B
cell potential of CLPs. This is compatible with the notion
that the B cell differentiation program is already active be-
fore being rendered irreversible by Pax5 (13). The analysis of
mice deficient for either EBF or Pax5 shows that Pax5 is
necessary in B cell differentiation at a later stage than EBF
because EBF    cells neither express Pax5 nor undergo
heavy chain rearrangements (16), whereas Pax5 deficiency
allows B cell development to progress until the D-JH rear-
rangement stage (17, 45).
The impairment of the B cell differentiation potential,
consequent to IL-7 deficiency in adult mice, is likely due to
low expression of Ebf, as overexpression of this B cell–specific
transcription factor sufficed to fully restore the B cell precur-
sor activity of the BM CLPs. This indicates that Ebf expres-
sion activates the B lineage program in lymphoid progenitors.
Furthermore, closing the B cell program (i.e., down-modula-
tion of Ebf), does not irreversibly engage cells in the T–NK
differentiation pathway. Our results agree with the observa-
tion that Ebf, but not Pax5, rescues B cell development in
E47- or PU.1-deficient fetal liver progenitors (46, 47).
It was recently observed that the expression of a constitu-JEM VOL. 201, March 21, 2005 977
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tively active form of STAT5b overcomes the B cell differen-
tiation block in IL-7R     mice (48) and the authors hy-
pothesized that this is achieved by modulation of Pax5
activity. Based on our results, we suggest that EBF is a more
likely candidate transcription factor necessary in the very
early phases of B cell differentiation. The B cell–specific reg-
ulation of recombinase activity that is observed in CLPs (49)
may also be secondary to IL-7 signaling. IL-7 activates the
JAK/STAT cascade as well as other pathways such as Ras/
Raf/Erk (50) or PI3K/AKT (51). Although no direct link
between IL-7 signaling and Ebf expression has been de-
scribed thus far, our results suggest that IL-7 regulates Ebf
expression in multipotent lymphoid progenitors.
MATERIALS AND METHODS
Mice.  C57BL/6 control mice (Ly5.1 or Ly5.2) were purchased from
Charles River Laboratories. IL-7    mice (28) in the C57BL/6 background
( 10 backcrosses) and Rag2 c    mice (52) were bred under specific
pathogen-free conditions at the Institut Pasteur. We analyzed young (4 wk
old) and adult (8–12 wk old) mice. All animal experiments were done in ac-
cordance to the guidelines of the Institut Pasteur, which are approved by
the French Ministry of Agriculture.
Cell sorting.  CLPs (Lin IL-7R  c-KitloSca-1 ) and HSCs (Lin IL-
7R  c-KithiSca-1hi) were isolated ( 97% purity) using a MoFlo CellSorter
(DakoCytomation). Freshly isolated BM cells were stained with PE-conju-
gated monoclonal antibodies for CD3  (145-2C11), CD4 (RM4-5), CD8 
(53–6.7), B220 (RA3-6B2), NK1.1 (PK136), CD11b (M1/70), Gr-1
(RB6-8C5), and Ter-119. Depletion of Lin  cells was performed by mag-
netic-activated cell separation using anti-PE MicroBeads (Miltenyi Biotec)
according to the manufacturer’s instructions. After depletion, the Lin  frac-
tion was treated with Fc-block (CD16/CD32) and stained with anti–Sca-1–
FITC (E13-161.7), anti–c-Kit–allophycocyanin (2B8), and with anti–
IL-7R  biotin (A7R34; reference 53). Streptavidin-Cy-chrome was used
to reveal the staining with the biotinylated antibody. Dead cells were stained
with propidium iodide and excluded by electronic gating. Flk-2 expression
was detected by staining sorted cells with anti–Flk-2–PE (A2F10.1).
Lin B220  cells were isolated after depletion with antibodies for CD3 ,
CD8 , CD19 (1D3), IgM (R6-60.2), NK1.1, CD11b, Gr-1, and Ter-119
and staining with anti-B220–FITC. All antibodies were purchased from BD
Biosciences except for the biotinylated anti–IL-7R , a gift from B. Rocha
(CHU Necker-Enfants Malades, Paris, France).
In vivo reconstitution.  CLPs were sorted from the BM of adult wild-
type or IL-7    mice, and 1,000 cells were injected intravenously in irradiated
(600 rad) Rag2 c    mice. 5 wk later, recipients were analyzed for the pres-
ence of donor type cells in the BM, spleen, and thymus, with a FACSCalibur
or a LSR flow cytometer and CELLQuest 3.3 software (Becton Dickinson).
Transplantation of fetal thymic lobes. Fetal thymic lobes from C57BL/6
Ly5.1 E15 embryos were irradiated (3,000 rad) and grafted under the kid-
ney capsule of adult IL-7    or control mice (four lobes per mouse). Mice
were killed four wk later and the lobes were analyzed for the presence of re-
cipient Ly5.2 T cells by flow cytometry. The absolute number of cells per
transplant was determined using a Neubauer chamber, excluding dead cells
with trypan blue. T cell subsets were analyzed by staining with monoclonal
antibodies for CD4, CD8, TCR   (GL3), CD25 (7D4), and CD44 (IM7).
Staining with monoclonal antibodies for CD3 , NK1.1, and CD19 was also
used to gate on DN T cells.
Limiting dilution assays.  The frequency of lymphoid precursors was
determined in limiting dilution assays as described previously (54) with some
modifications. OP9 stromal cells, a gift from T. Nakano (Osaka University,
Osaka, Japan) were seeded in 96-well plates (2,500 cells/well). A minimum
of 48 wells were analyzed per cell dilution. The culture medium was supple-
mented with saturating amounts of c-Kit ligand, Flk-2 ligand, IL-2, and IL-7.
For the clonal analysis of B/NK potential, we used purified hIL-2 (provided
by J.P. Di Santo, Institut Pasteur, Paris, France). These conditions also allow
myeloid differentiation from HSCs. The frequency of T and NK precursors
was determined by limiting dilution in FTOCs as described previously (55).
Scores were assigned to B cell (CD19 ) or myeloid colonies (CD11b ) on
days 10–12 or reconstituted FTOCs (CD4 /CD8 /TCR    or NK1.1 )
on days 14–15 by flow cytometry. The frequency of responding cells in each
population (estimated by fitting a generalized linear model and finding the
maximum likelihood using the Newton-Raphson method) and the signifi-
cance of the reported differences between populations (assessed by relying on
the asymptotic normality of the maximum likelihood estimates) were calcu-
lated using L-Calc software (StemSoft Software Inc.).
Quantitative RT-PCR analysis.  Cells (104–105) were directly sorted
on TRIzol (Invitrogen) or RNA-Plus (Qbiogene) and RNA was extracted
following the manufacturer’s instructions. Total cDNA was prepared using
Oligo-d(T)12-18 (Amersham Biosciences) with M-MLV Reverse Tran-
scriptase (Invitrogen) at 37 C for 50 min. 1/10 of the cDNA was used in
each quantitative assay using SYBR green PCR core reagents (Applied Bio-
systems) and detection was done using an ABI Prism 7000 Sequence Detection
System (Applied Biosystems). For each target cDNA, the pair of primers
permits the amplification of a multi-exon sequence: Hprt, forward, 5 -GT-
TCTTTGCTGACCTGCTGG-3  and reverse 5 -TCCAACACTTCG-
AGAGGTCC-3 ; Ebf, forward 5 -AACTGGCTGTGAATGTCTCG-3 
and reverse 5 -TCACATGGGAGGGACAATCA-3 ; Pax5, forward 5 -
TCCTCGGACCATCAGGACAG-3  and reverse 5 -CCTGTTGATG-
GAGCTGACGC-3 ; and Gata-3, forward 5 -TCGGCCATTCGTACA-
TGGAA-3  and reverse 5 -GAGAGCCGTGGTGGATGGAC-3 . Cy-
cling conditions were as follows: 1 cycle of 10 min at 94 C; 45 cycles of 30 s
at 94 C; 30 s at 60 C (Pax5, Gata-3) or 63 C (Hprt, Ebf); and 45 s at 72 C.
Product size was confirmed by gel electrophoresis. Primer-dimer formation
was monitored by gel electrophoresis and with the dissociation protocol.
The amounts of Ebf, Pax5, or Gata-3 in each sample were calculated with
ABI Prism 7000 Sequence Detection System software (Applied Biosystems)
and normalized to the amount of Hprt.
Retroviral transduction. The MSCV-pgk.1-IRES-eGFP (MIEV) retro-
viral vector, a gift from G. Wu (University of Toronto, Toronto, Canada),
has been described previously (56). The coding regions of murine Pax5 and
rat Ebf (provided by B. Kee, University of Chicago, Chicago, IL) were
blunt-end cloned into the SnaBI site of MIEV, the orientation was con-
firmed by restriction analysis to generate MIEV, MIEV–Pax5, and MIEV–
EBF vectors. The ecotropic packaging cell line Plat-E (provided by T. Kitamura,
Institute of Medical Science, Tokyo, Japan; reference 57) was transiently
transfected using Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. Viral supernatant was harvested 48 h after transfec-
tion, filtered through a 45- m membrane (Sartorius), and incubated for 5
min on ice with 2.5  g/ml of polybrene (Sigma-Aldrich). Sorted cells were
cultured overnight with saturating concentrations of c-Kit ligand, Flk-2
ligand, and IL-7, followed by two serial spin-infections (1,800 revolutions/
min at 32 C, for 45 min) with a 24-h interval. After infection, cells were
counted and used in limiting dilution assays as described before. We esti-
mated the efficiency of transduction by analyzing GFP expression, 48 h after
infection, in Lin  BM cells. GFP expression was detected by flow cytome-
try in 52, 18, and 10% of the cells transduced with MIEV, MIEV-Pax5, or
MIEV-EBF, respectively.
Online supplemental material. Fig. S1 shows that adult IL-7    thymic
precursors are able to migrate and repopulate a thymus. Fig. S2 shows a
schematic representation of the retroviral vectors. Table S1 shows the fre-IL-7 AND B POTENTIAL IN CLPS | Dias et al. 978
quency of Sca-1low and Sca-1high CLPs able to give rise to B, T, or NK cells.
Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20042393/DC1.
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